NCT00848640
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Egyptian Foundation For Cancer Research Cairo, Egypt
Clinical trial condition
Metastatic Renal Cell Carcinoma
Explore clinical trials studying Metastatic Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.
125 public trials
25 recruiting studies
Metastatic Renal Cell Carcinoma trial results
NCT00625768
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
- Locations
-
- Auckland Medical School Auckland, New Zealand
- Waikato DHB Hamilton, New Zealand
- Guys Hospital London, United Kingdom
- Charing Cross Hospital London, United Kingdom
NCT00421512
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, United States
NCT00291369
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Centre Leon Berard Lyon, France
Active, Not Recruiting
Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
NCT03647878
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- Landeskrankenhaus Hochsteiermark Leoben, Austria
- Kepler Universitätsklinikum GmbH Linz, Austria
- Uniklinikum Salzburg Salzburg, Austria
- Salzkammergutklinikum Vöcklabruck Vöcklabruck, Austria
Active, Not Recruiting
Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
NCT02298959
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +60 more
- Locations
-
- Moffitt Cancer Center-International Plaza Tampa, Florida, United States
- Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
Active, Not Recruiting
Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study
NCT05863351
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Poudre Valley Hospital Fort Collins, Colorado, United States
Active, Not Recruiting
Cancer and Blood Pressure Management, CARISMA Study
NCT04467021
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +36 more
- Locations
-
- Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
- Montefiore Medical Center-Weiler Hospital The Bronx, New York, United States
Active, Not Recruiting
Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
NCT03541902
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- MD Anderson Regional Care Center-Katy Houston, Texas, United States
- MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States
Active, Not Recruiting
Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
NCT03587662
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States